Antibiotic chemotherapy during pregnancy and lactation period: Aspects for consideration

Archives of Gynecology and Obstetrics

Volumn 283, Issue 1, 2011, Pages 7-18

  Mylonas, Ioannis ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adverse outcome; Antibiotics; Contraindication; Pregnancy; Treatment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; CEFOTETAN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; GYRASE INHIBITOR; LINCOMYCIN; LINCOSAMIDE DERIVATIVE; MACROLIDE; METRONIDAZOLE; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLIN V; PIVMECILLINAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SPIRAMYCIN; STREPTOMYCIN; SULFAMETHOXAZOLE; SULFONAMIDE; TEICOPLANIN; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ACNE; ANAEROBIC INFECTION; ANAPHYLACTIC SHOCK; ANTIBIOTIC THERAPY; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BACTERICIDAL ACTIVITY; BACTEROIDES INFECTION; BLOOD CELL COUNT; BONE MARROW DISEASE; BORRELIA INFECTION; BRONCHITIS; CARCINOGENICITY; CENTRAL NERVOUS SYSTEM DISEASE; CHORIOAMNIONITIS; CYSTITIS; DELAYED HYPERSENSITIVITY; DIARRHEA; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG DIFFUSION; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG PENETRATION; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG UPTAKE; EMBRYOTOXICITY; ENDOMETRITIS; ENTEROBACTERIACEAE INFECTION; FATALITY; FETUS RISK; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GONORRHEA; HEMOLYSIS; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INJECTION SITE REACTION; INTERSTITIAL NEPHRITIS; LACTATION; LISTERIOSIS; LIVER INJURY; MASTITIS; MENINGITIS; MUTAGENICITY; NAUSEA; NONHUMAN; PELVIC INFLAMMATORY DISEASE; PNEUMONIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRENATAL DRUG EXPOSURE; PYELONEPHRITIS; PYLORUS STENOSIS; SEPSIS; SIDE EFFECT; SINGLE DRUG DOSE; SPONTANEOUS ABORTION; SYPHILIS; TERATOGENICITY; THROMBOPHLEBITIS; TOXOPLASMOSIS; TRICHOMONIASIS; URINARY TRACT INFECTION; UTERINE CERVICITIS; VAGINITIS; VESTIBULOCOCHLEAR NERVE DISEASE; VOMITING; VULVITIS; WOUND INFECTION;

ABNORMALITIES, DRUG-INDUCED; ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASES; DNA GYRASE; FEMALE; HUMANS; LACTATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 78751574217     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-010-1646-3     Document Type: Article

References (55)

1. I Mylonas D Dian K Friese 2005 Antibiotikatherapie in der Schwangerschaft Gynakologe 38 761 770 1:CAS:528:DC%2BD2MXhtVentLvE 10.1007/s00129-005-1734-9 (Pubitemid 41367385)
2. Mylonas I, Friese K (2009) Infektionen in der Gynäkologien und Geburtshilfe. Elsevier Verlag/Urban & Fischer, München
3. Friese K, Schäfer A, Hof H (2002) Infektionen in der Gynäkologie und Geburtshilfe. Springer, Berlin
4. Friese K, Mörike K, Neumann G, Windorfer A (2009) Arzneimittel in der Schwangerschaft und Stillzeit: Ein Leitfaden für Ärzte und Apotheker Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
5. Friese K, Melchert F (2002) Arzneimitteltherapie in der Frauenheilkunde. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart
6. Briggs GG, Freeman RK, Yaffe SJ (1998) Drugs in pregnancy and lactation. Williams & Wilkins, Baltimore
7. EJ Saunders JA Saunders 1990 Drug therapy in pregnancy: the lessons of diethylstilbestrol, thalidomide, and bendectin Health Care Women Int 11 423 432 1:STN:280:DyaK3M%2FjsFSitA%3D%3D 10.1080/07399339009515912 2228814
8. -(2001) Erythromycin-induced pyloric stenosis in infants. Prescrire Int 10:16
9. BE Mahon MB Rosenman MB Kleiman 2001 Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis J Pediatr 139 380 384 1:CAS:528: DC%2BD3MXnslSlsrc%3D 10.1067/mpd.2001.117577 11562617 (Pubitemid 32889514)
10. M Norgaard MV Skriver HT Sorensen HC Schonheyder L Pedersen 2008 Risk of miscarriage for pregnant users of pivmecillinam: a population-based case-control study APMIS 116 278 283 18397462
11. F Sa del Fiol M Gerenutti FC Groppo 2005 Antibiotics and pregnancy Pharmazie 60 483 493 1:STN:280:DC%2BD2Mvht1eksg%3D%3D 16076072
12. U Amann V Egen-Lappe C Strunz-Lehner J Hasford 2006 Antibiotics in pregnancy: analysis of potential risks and determinants in a large German statutory sickness fund population Pharmacoepidemiol Drug Saf 15 327 337 10.1002/pds.1225 16557603 (Pubitemid 43797120)
13. T Bertsche M Haas H Oberwittler WE Haefeli I Walter-Sack 2006 Drugs during pregnancy and breastfeeding: new risk categories-antibiotics as a model Dtsch Med Wochenschr 131 1016 1022 1:CAS:528:DC%2BD28XmsVSmurY%3D 10.1055/s-2006-939888 16673226 (Pubitemid 44173897)
14. GG Nahum K Uhl DL Kennedy 2006 Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks Obstet Gynecol 107 1120 1138 1:CAS:528:DC%2BD28XkvFGhtrg%3D 10.1097/01.AOG.0000216197.26783.b5 16648419
15. A Haas G Maschmeyer 2008 Antibiotic therapy in pregnancy Dtsch Med Wochenschr 133 511 515 1:CAS:528:DC%2BD1cXltlCiurw%3D 10.1055/s-2008-1046742 18320483 (Pubitemid 351487214)
16. Schäfer C, Spielman H (2001) Arzneimittelverordnung in Schwangerschaft und Stillzeit. Elsevier Urban und Fischer, Berlin, Jena
17. BB Dencker H Larsen ES Jensen HC Schonheyder GL Nielsen HT Sorensen 2002 Birth outcome of 1886 pregnancies after exposure to phenoxymethylpenicillin in utero Clin Microbiol Infect 8 196 201 1:CAS:528:DC%2BD38XkvVymsbo%3D 10.1046/j.1469-0691.2002.00368.x 12047410 (Pubitemid 34993786)
18. DF Lewis CD Adair AG Robichaux RK Jaekle JA Moore AT Evans MT Fontenot 2003 Antibiotic therapy in preterm premature rupture of membranes: are seven days necessary? A preliminary, randomized clinical trial Am J Obstet Gynecol 188 1413 1416 1:CAS:528:DC%2BD3sXltF2jurw%3D 10.1067/mob.2003.382 12824971 (discussion 1416-1417) (Pubitemid 36741267)
19. AE Czeizel M Rockenbauer HT Sorensen J Olsen 2001 Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case-control teratologic study Eur J Obstet Gynecol Reprod Biol 97 188 192 1:CAS:528:DC%2BD3MXltVartLw%3D 10.1016/S0301-2115(00)00545-5 11451547 (Pubitemid 32645654)
20. TR Sigg BR Kuhn 2000 Inadvertent intrauterine infusion of ampicillin-sulbactam Am J Health Syst Pharm 57 215 1:STN:280: DC%2BD3c7jslagug%3D%3D 10674773
21. Simon C, Stille W (2000) Antibiotika-Therapie in Klinik und Praxis. Schattauer, Stuttgart
22. G Garratty RM Leger PA Arndt 1999 Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures Am J Obstet Gynecol 181 103 104 1:STN:280:DyaK1MzjvFOlug%3D%3D 10.1016/S0002-9378(99)70443-6 10411803 (Pubitemid 29343338)
23. M Berkovitch I Segal-Socher R Greenberg M Bulkowshtein J Arnon P Merlob A Or-Noy 2000 First trimester exposure to cefuroxime: a prospective cohort study Br J Clin Pharmacol 50 161 165 1:CAS:528:DC%2BD3cXmsFamtrw%3D 10.1046/j.1365-2125.2000.00240.x 10930968 (Pubitemid 30612034)
24. AE Czeizel M Rockenbauer HT Sorensen J Olsen 2001 Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: a population-based, case-control study Am J Obstet Gynecol 184 1289 1296 1:CAS:528:DC%2BD3MXksFams7o%3D 10.1067/mob.2001.113905 11349204 (Pubitemid 32434289)
25. W Manka R Solowiow D Okrzeja 2000 Assessment of infant development during an 18-month follow-up after treatment of infections in pregnant women with cefuroxime axetil Drug Saf 22 83 88 1:STN:280:DC%2BD3c7ht1Gjtg%3D%3D 10.2165/00002018-200022010-00007 10647978
26. A Heikkila R Erkkola 1994 Review of β-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules Clin Pharmacokinet 27 49 62 1:STN:280:DyaK2M%2Fktlyjsg%3D%3D 10.2165/00003088-199427010-00005 7955771
27. AE Czeizel M Rockenbauer HT Sorensen J Olsen 1999 A population-based case-control teratologic study of oral erythromycin treatment during pregnancy Reprod Toxicol 13 531 536 1:CAS:528:DyaK1MXnvFeltbw%3D 10.1016/S0890-6238(99) 00046-5 10613401 (Pubitemid 30017329)
28. A Einarson E Phillips F Mawji D D'Alimonte B Schick A Addis P Mastroiacova T Mazzone D Matsui G Koren 1998 A prospective controlled multicentre study of clarithromycin in pregnancy Am J Perinatol 15 523 525 1:STN:280:DyaK1M7gsFamtg%3D%3D 10.1055/s-2007-994053 9890248 (Pubitemid 29017981)
29. B Schick M Hom R Librizzi A Donnenfeld 1996 Pregnancy outcome following exposure to clarithromycin Reprod Toxicol 10 162
30. AE Czeizel M Rockenbauer J Olsen HT Sorensen 2000 A case-control teratological study of spiramycin, roxithromycin, oleandomycin and josamycin Acta Obstet Gynecol Scand 79 234 237 1:STN:280:DC%2BD3c7nvFSmsw%3D%3D 10.1080/j.1600-0412.2000.079003234.x 10716307
31. BA Kallen P Otterblad Olausson BR Danielsson 2005 Is erythromycin therapy teratogenic in humans? Reprod Toxicol 20 209 214 15907655
32. Schardein JL (2000) Chemically induced birth defects. Marcel Dekker, New York
33. JH Lewis 1991 Drug hepatotoxicity in pregnancy Eur J Gastroenterol Hepatol 3 883 891
34. MF Trexler TG Fraser MP Jones 1997 Fulminant pseudomembranous colitis caused clindamycin phosphate vaginal cream Am J Gastroenterol 92 2113
35. Joesoef M, Schmid G (2002) Bacterial vaginosis. Clin Evid 1592-1600
36. AE Czeizel M Rockenbauer J Olsen HT Sorensen 2000 A teratological study of aminoglycoside antibiotic treatment during pregnancy Scand J Infect Dis 32 309 313 1:CAS:528:DC%2BD3MXhslGgtbs%3D 10.1080/00365540050165974 10879604
37. CD Freeman NE Klutman KC Lamp 1997 Metronidazole: a therapeutic review and update Drugs 54 679 708 1:CAS:528:DyaK2sXntlyiurw%3D 10.2165/00003495- 199754050-00003 9360057
38. O Diav-Citrin T Gotteiner S Shechtman J Arnon A Ornoy 2000 Pregnancy outcome following gestational exposure to metronidazole: a prospective controlled cohort study (abstract) Teratology 61 440
39. PB Thapa JA Whitlock KG Brockman Worrell P Gideon EF Mitchel P Roberson R Pais WA Ray 1998 Prenatal exposure to metronidazole and risk of childhood cancer Cancer 83 1461 1468 1:CAS:528:DyaK1cXms1Cisbg%3D 10.1002/(SICI)1097- 0142(19981001)83:7<1461::AID-CNCR25>3.0.CO;2-1 9762949 (Pubitemid 28460099)
40. CM Beard KL Noller WM O'Fallon LT Kurland DC Dahlin 1988 Cancer after exposure to metronidazole Mayo Clin Proc 63 147 153 1:CAS:528:DyaL1cXhsVaqsLw%3D 3339906
41. T Caro-Paton A Carvajal I Martin de Diego LH Martin-Arias A Alvares-Requejo E Rodriguez-Pinilla 1997 Is metronidazole teratogenic? A meta-analysis Br J Clin Pharmacol 44 179 182 1:CAS:528:DyaK2sXls1Wrs7w%3D 10.1046/j.1365-2125.1997.00660.x 9278206
42. AE Czeizel M Rockenbauer 1998 A population based case-control teratologic study of oral metronidazole treatment during pregnancy Br J Obstet Gynaecol 105 2 7
43. AE Czeizel 1990 A case-control analysis of the teratogenic effects of co-trimoxazole Reprod Toxicol 4 305 313 1:CAS:528:DyaK3MXhslOqsLs%3D 10.1016/0890-6238(90)90042-T 2136050
44. Heinonen OP, Slone D, Shapiro S (1977) Birth defects and drugs in pregnancy. Publishing Sciences Group, Littleton
45. K Friese H Hlobil 1997 Prenatal toxoplasmosis: is screening in pregnancy necessary? Z Geburtshilfe Neonatol 201 115 120 1:STN:280:DyaK2svnsFKgtA%3D%3D 9410515
46. K Friese 1994 Diagnosis and treatment of congenital toxoplasmosis Geburtshilfe Und Frauenheilkunde 54 M99 M101 1:STN:280:DyaK2M%2FntlGktA%3D%3D 7982543
47. RE Wenk FC Gebhardt BS Bhagavan JA Lustgarten EF McCarthy 1981 Tetracycline-associated fatty liver of pregnancy, including possible pregnancy risk after chronic dermatologic use of tetracycline J Reprod Med 26 135 141 1:STN:280:DyaL3M7psVGmtA%3D%3D 7230149
48. PJ Whalley FG Martin RH Adams B Combes 1970 Disposition of tetracycline by pregnant women with acute pyelonephritis Obstet Gynecol 36 821 826 1:STN:280:DyaE3M%2FlvFSkug%3D%3D 5487732
49. AE Czeizel M Rockenbauer 2000 A population-based case-control study of oral oxytetracycline treatment during pregnancy Eur J Obstet Gynecol Reprod Biol 88 27 33 1:CAS:528:DC%2BD3cXivF2nsQ%3D%3D 10.1016/S0301-2115(99)00112-8 10659913 (Pubitemid 30009367)
50. S Takayama T Watanabe Y Akiyama K Ohura S Harada K Matsuhashi K Mochida N Yamashita 1986 Reproductive toxicity of ofloxacin Arzneimittelforschung 36 1244 1248 1:CAS:528:DyaL28XlsVGks7Y%3D 3465327
51. AW Gough OB Kasali RE Sigler V Baragi 1992 Quinolone arthropathy acute toxicity to immature articular cartilage Toxicol Pathol 20 436 449 1:CAS:528:DyaK3sXitVCmsr4%3D 10.1177/019262339202000319 1295072
52. C Schaefer E Amoura-Elefant T Vial A Ornoy H Garbis E Robert E Rodriguez-Pinilla T Pexieder N Prapas P Merlob 1996 Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS) Eur J Obstet Gynecol Reprod Biol 69 83 89 1:STN:280:DyaK2s%2FlvVWjuw%3D%3D 10.1016/0301-2115(95)02524-3 8902438 (Pubitemid 26338311)
53. M Berkovitch A Pastuszak M Gazarian M Lewis G Koren 1994 Safety of the new quinolones in pregnancy Obstet Gynecol 84 535 538 1:STN:280: DyaK2cznslSktw%3D%3D 8090389
54. R Loebstein A Addis E Ho R Andreou, et al. 1998 Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study Antimicrob Agents Chemother 42 1336 1339 1:STN:280: DyaK1c3oslGltQ%3D%3D 9624471
55. MR Holdiness 1987 Teratology of the antituberculosis drugs Early Hum Dev 15 61 74 1:STN:280:DyaL2s3ks1agug%3D%3D 10.1016/0378-3782(87)90039-9 3297625 (Pubitemid 17055827)